510(k) K182123
K182123 is an FDA 510(k) premarket notification submitted by Advin Biotech, Inc. for the device "ATTEST Drug Screen Cup, ATTEST Drug Screen Dip Card". The FDA issued a decision of Substantially Equivalent on March 29, 2019. The device falls under product code DJG (Enzyme Immunoassay, Opiates), a Class II device regulated under 21 CFR 862.3650. Advin Biotech, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 29, 2019
- Date Received
- August 6, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Opiates
- Device Class
- Class II
- Regulation Number
- 862.3650
- Review Panel
- TX
- Submission Type